• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替勃龙对绝经后子宫肌瘤妇女的长期影响。

Long term effects of Tibolone on postmenopausal women with uterine myomas.

作者信息

Gregoriou O, Konidaris S, Botsis D, Papadias C, Makrakis E, Creatsas G

机构信息

2nd Department of Obstetrics and Gynecology, University of Athens, Areteion Hospital, 76 Vas Sophias Ave, Athens 115 28, Greece.

出版信息

Maturitas. 2001 Oct 31;40(1):95-9. doi: 10.1016/s0378-5122(01)00234-1.

DOI:10.1016/s0378-5122(01)00234-1
PMID:11684378
Abstract

OBJECTIVES

The aim of the present study is to evaluate the long term effects of Tibolone (Livial) on uterine myomas volume as well as on uterine arteries pulsatility index (PI) in postmenopausal women.

METHODS

This study included 66 naturally menopausal women. Twenty of them (group A) had no uterine myomas; 23 of them (group B) had a single, asymptomatic, intramural or subserous myoma of a maximum diameter less or equal than 2 cm; 23 of them (group C) had a single, asymptomatic, intramural or subserous myoma of a maximum diameter between 2 and 5 cm. The volume of the myomas as well as the pulsatility index of the uterine arteries was assessed by transvaginal ultrasonography every 6 months after administration of Tibolone (2.5 mg daily).

RESULTS

No statistically significant difference on myomas volume was found after a 3-year period of Tibolone administration. The uterine artery basal PI was significantly higher in group A compared to that of groups B and C. After 6 months of Tibolone administration the PI in group A was significantly lower compared to the basal one whereas in groups B and C was significantly higher compared to the basal value.

CONCLUSIONS

Our results suggest that treating postmenopausal woman with Tibolone on a long-term basis: (a) does not increase the volume of uterine myomas and (b) has an early effect on uterine haemodynamics (decrease of PI in women without myomas and increase of PI in women with myomas).

摘要

目的

本研究旨在评估替勃龙(利维爱)对绝经后女性子宫肌瘤体积以及子宫动脉搏动指数(PI)的长期影响。

方法

本研究纳入66名自然绝经女性。其中20名(A组)无子宫肌瘤;23名(B组)有单个无症状肌壁间或浆膜下肌瘤,最大直径小于或等于2 cm;23名(C组)有单个无症状肌壁间或浆膜下肌瘤,最大直径在2至5 cm之间。在给予替勃龙(每日2.5 mg)后,每6个月通过经阴道超声评估肌瘤体积以及子宫动脉搏动指数。

结果

在给予替勃龙3年期间,未发现肌瘤体积有统计学显著差异。A组子宫动脉基础PI显著高于B组和C组。给予替勃龙6个月后,A组PI与基础值相比显著降低,而B组和C组PI与基础值相比显著升高。

结论

我们的结果表明,长期用替勃龙治疗绝经后女性:(a)不会增加子宫肌瘤体积;(b)对子宫血流动力学有早期影响(无肌瘤女性PI降低,有肌瘤女性PI升高)。

相似文献

1
Long term effects of Tibolone on postmenopausal women with uterine myomas.替勃龙对绝经后子宫肌瘤妇女的长期影响。
Maturitas. 2001 Oct 31;40(1):95-9. doi: 10.1016/s0378-5122(01)00234-1.
2
Effect of tibolone on postmenopausal women with myomas.替勃龙对绝经后子宫肌瘤妇女的影响。
Maturitas. 1997 Jun;27(2):187-91. doi: 10.1016/s0378-5122(97)00036-4.
3
A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.一项关于替勃龙与经皮雌激素替代疗法对绝经后子宫肌瘤妇女影响的随机研究。
Eur J Obstet Gynecol Reprod Biol. 2000 Jan;88(1):91-4. doi: 10.1016/s0301-2115(99)00115-3.
4
Effects of hormone replacement therapy on postmenopausal uterine myoma.
Maturitas. 2000 May 29;35(2):167-73. doi: 10.1016/s0378-5122(00)00115-8.
5
Transvaginal Doppler examination of uteri with myomas.子宫肌瘤的经阴道多普勒检查。
J Clin Ultrasound. 1996 Mar-Apr;24(3):135-40. doi: 10.1002/(SICI)1097-0096(199603)24:3<135::AID-JCU5>3.0.CO;2-I.
6
Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.不同激素替代疗法方案对绝经后期子宫肌瘤大小的影响:替勃龙与经皮激素替代系统的比较
Maturitas. 2002 Jul 25;42(3):243-6. doi: 10.1016/s0378-5122(02)00081-6.
7
A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata.一项关于替勃龙与促性腺激素释放激素类似物联合给药治疗子宫平滑肌瘤效果的临床试验。
Fertil Steril. 1998 Jul;70(1):111-8. doi: 10.1016/s0015-0282(98)00128-9.
8
The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study.雷洛昔芬和替勃龙对子宫血流及子宫内膜厚度的影响:经阴道多普勒研究
Maturitas. 2006 Feb 20;53(3):362-8. doi: 10.1016/j.maturitas.2005.06.010. Epub 2005 Sep 12.
9
[The effects of menopausal replacement therapy in women with uterine myomas].
Minerva Ginecol. 1999 Nov;51(11):421-5.
10
[Low-dose combination oral contraceptives use in women with uterine leiomyomas].子宫平滑肌瘤女性使用低剂量复方口服避孕药
Minerva Ginecol. 2002 Jun;54(3):253-61.

引用本文的文献

1
Management of Common Benign Gynecologic Diseases in Postmenopausal Women.绝经后女性常见良性妇科疾病的管理
J Menopausal Med. 2024 Dec;30(3):135-142. doi: 10.6118/jmm.24017.
2
Selective estrogen receptor modulator with estrogen does not affect the proliferation and apoptosis of uterine leiomyoma cells.选择性雌激素受体调节剂与雌激素联合使用不影响子宫肌瘤细胞的增殖和凋亡。
Transl Cancer Res. 2020 Sep;9(9):5390-5400. doi: 10.21037/tcr-19-3022a.
3
The exceptional case of a large extra-uterine, so-called parasitic leiomyoma in a post-menopausal woman with Hashimoto's thyroiditis.
一名患有桥本甲状腺炎的绝经后女性出现巨大宫外所谓寄生性平滑肌瘤的罕见病例。
Facts Views Vis Obgyn. 2021 Jan 8;12(4):319-323.
4
The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.绝经后子宫肌瘤妇女激素替代治疗的影响:文献的最新综述。
Medicina (Kaunas). 2019 Aug 30;55(9):549. doi: 10.3390/medicina55090549.
5
Effect of Isopropanolic Cimicifuga racemosa Extract on Uterine Fibroids in Comparison with Tibolone among Patients of a Recent Randomized, Double Blind, Parallel-Controlled Study in Chinese Women with Menopausal Symptoms.近期在中国有一项针对围绝经期症状妇女的随机、双盲、平行对照研究,比较了异丙醇升麻属植物提取物与替勃龙对子宫肌瘤的影响。
Evid Based Complement Alternat Med. 2014;2014:717686. doi: 10.1155/2014/717686. Epub 2014 Mar 2.